Neural Therapeutics Inc
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$2.53M
-0.01
Neural Therapeutics, Inc. is an ethnobotanical drug-discovery company, which engages in the research and development of dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. The firm's approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract. Its initial focus is the San Pedro (Echinopsis pachanoi or Trichocereus pachanoi), a cactus containing mescaline. The firm has approximately 30.75% of the equity interest in CWE European Holdings Inc., the owner and operator of a business known as Hanf.com (Hanf.com), one of Germany's CBD retailers. Hanf.com's retail and eCommerce operations include 15 stores in Germany (11 directly owned and four franchises).
Neural Therapeutics, Inc. is an ethnobotanical drug-discovery company, which engages in the research and development of dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. The firm's approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract. Its initial focus is the San Pedro (Echinopsis pachanoi or Trichocereus pachanoi), a cactus containing mescaline. The firm has approximately 30.75% of the equity interest in CWE European Holdings Inc., the owner and operator of a business known as Hanf.com (Hanf.com), one of Germany's CBD retailers. Hanf.com's retail and eCommerce operations include 15 stores in Germany (11 directly owned and four franchises).
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.